Federal tobacco oversight rising from the ashes
Thursday, July 24, 2008 12:49 AM PDT
July 24 Daily News editorial
Over the past decade, tobacco companies have managed to beat back repeated efforts in Congress to bring their products under U.S. Food and Drug Administration oversight. But Big Tobacco’s winning streak is in jeopardy this summer. Committees in both the House and Senate have voted overwhelmingly to advance legislation that would give the federal agency the authority to regulate tobacco as an addictive drug.
The legislation appears to be headed for easy approval in the House, perhaps within the week. Its fate is less certain in the Senate, but with 57 senators signed on as co-sponsors, there’s cause for optimism. The legislation enjoys bipartisan support in both chambers. Only the clock is working against it. Both the House and Senate need to bring this legislation to the floor before Congress adjourns Aug. 10 for its summer recess to ensure that the measure doesn’t stall and die at the end of the year.
It’s time that federal health authorities finally be given the power to regulate nicotine. It’s been seven years since a presidential commission unanimously recommended that the FDA be given this regulatory authority.
The agency, in fact, has resisted calls from anti-smoking advocates to regulate nicotine for at least a couple of decades, insisting that it had no such authority so long as tobacco companies avoided making claims that their products were providing health benefits. The FDA reversed itself in 1996, when it classified tobacco products as “drugs” and “devices” subject to federal regulation. But four years later, the U.S. Supreme Court ruled that the agency was wrong to claim that regulatory authority — that Congress would have to grant it.
Congress’ initial opposition to granting the FDA regulatory authority over tobacco products has softened in the years since. A 2007 Harvard School of Public Health study showing that the tobacco industry may have manipulated nicotine content did much to soften congressional opposition. Indeed, the regulatory legislation now pending in the House and Senate was introduced shortly after the release of that study, which found that nicotine levels in cigarettes had steadily increased between 1997 and 2005.
The pending legislation would not give the FDA the authority either to ban nicotine or outlaw tobacco. But the agency could force reductions of nicotine levels in tobacco products and direct tobacco companies to remove harmful additives from their products. It's a workable compromise — one supported by many one-time opponents of regulation, including tobacco’s Philip Morris.
Tobacco-related illnesses claim more than 400,000 lives and cost the nation $94 billion in health-care bills every year, according to the American Cancer Society. The federal oversight this legislation would allow is only sensible and long overdue.
TDN Bad Boy wrote on Jul 24, 2008 8:07 AM:
Cheney119 wrote on Jul 24, 2008 4:39 PM:
TDN Bad Boy wrote on Jul 24, 2008 10:14 PM:
Cheney119 wrote on Jul 24, 2008 10:57 PM:
TDN Bad Boy wrote on Jul 25, 2008 8:29 AM:






Printable version
E-mail this article

Past Month's Most Commented Stories